| Schedule of Finite-Lived Intangible Assets |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | March 31, 2025 | | December 31, 2024 | March 31, 2024 | | (In millions) | Gross | Accumulated
Amortization | Net | | Gross | Accumulated
Amortization | Net | Gross | Accumulated
Amortization | Net | | Intangible assets subject to amortization (finite-lived): | | | | | | | | | | | | Germplasm | $ | 6,291 | | $ | (1,399) | | $ | 4,892 | | | $ | 6,291 | | $ | (1,336) | | $ | 4,955 | | $ | 6,291 | | $ | (1,145) | | $ | 5,146 | | | Customer-related | 2,349 | | (896) | | 1,453 | | | 2,350 | | (863) | | 1,487 | | 2,421 | | (766) | | 1,655 | | | Developed technology | 1,838 | | (1,197) | | 641 | | | 1,838 | | (1,161) | | 677 | | 1,846 | | (1,050) | | 796 | | | Trademarks/trade names | 2,056 | | (402) | | 1,654 | | | 2,056 | | (380) | | 1,676 | | 2,111 | | (361) | | 1,750 | | | | | | | | | | | | | Other1 | 388 | | (315) | | 73 | | | 388 | | (312) | | 76 | | 395 | | (301) | | 94 | | | Total other intangible assets with finite lives | 12,922 | | (4,209) | | 8,713 | | | 12,923 | | (4,052) | | 8,871 | | 13,064 | | (3,623) | | 9,441 | | | | | | | | | | | | | | Intangible assets not subject to amortization (indefinite-lived): | | | | | | | | | | | | In-process research & development | 5 | | — | | 5 | | | 5 | | — | | 5 | | 5 | | — | | 5 | | Total other intangible assets with
indefinite lives | 5 | | — | | 5 | | | 5 | | — | | 5 | | 5 | | — | | 5 | | | Total other intangible assets | $ | 12,927 | | $ | (4,209) | | $ | 8,718 | | | $ | 12,928 | | $ | (4,052) | | $ | 8,876 | | $ | 13,069 | | $ | (3,623) | | $ | 9,446 | |
1.Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.
|